post document plainly lilly national institute mental health key opinion leaders made data prozac suicide vanish poof study known study published graham emslie lead author differs notably fda report data study published paper mention suicidal ideation whatsoever none however according fda report read page report clearly referencing study yet even passing mention suicide provided published paper regarding different medication lead investigator study graham emslie asked one point sharing data showing paxil seroxat effective treatment child adolescent depression responded follows i talk proprietary words gsk owned data could mention negative information unless permission humble opinion gives impression emslie scientist rather sock puppet drug industry back study would emslie lead author study insist suicide attempt data included study publication nimh theoretically owned data funded study would make sure publish important information one thing exclude data two patients prozac say treatment emergent flatulence quite another exclude data much troubling treatment emergent event suicide attempts i first notice issue previously mentioned jonathan leo letter editor psychiatric times i see incidence hiding suicide data i think nimh poor attempts journalism regarding ssri suicide issue raises suspicions regarding whose agenda served agency whose opinion matters also note yet frequently mentioned ssri terrific kids crowd depression measures completed children adolescents study showed significant improvement versus placebo nearly always case studies examining ssris child adolescent depression measures rated clinicians occasionally found advantage ssris youth depression yet almost never effects extended youths perceptions depression call me crazy going say treatment effective depression yet people depressed say relieve depression raise suspicion authors however try squirm difficult position following sentences furthermore self reported depressive symptom measurements also showed improvement groups group differences significant however given wide variability initial child self reports findings difficult interpret oh i get significant advantage shown measure rated clinicians difficult interpret drug shown effective placebo well knows might mean nice attempt obfuscation part authors think drug company funded study hid negative data obfuscated negative findings yet good old nimh tax dollars behind work worry friends study conclusion published flagship journal psychiatry archives general psychiatry reads follows data indicate fluoxetine mg safe effective children adolescents back graham emslie admits helping keep gsk secret paxil effective treatment youth depression lead investigator study two suicide attempts appear deep sixed interpretations research regarding effexor guessed youth depression also seem overly positive seems helped keep data effexor youth depression buried several years worry according website known internationally work treatment pediatric depression indeed i comforted know expect high caliber work high ranking academic psychiatrists